Liquidia Corp (LQDA)
12.87
+0.01
(+0.08%)
USD |
NASDAQ |
May 31, 16:00
14.42
+1.55
(+12.04%)
After-Hours: 20:00
Liquidia Gross Profit (TTM): 12.27M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 12.27M |
December 31, 2023 | 14.60M |
September 30, 2023 | 15.73M |
June 30, 2023 | 15.04M |
March 31, 2023 | 14.12M |
December 31, 2022 | 13.08M |
September 30, 2022 | 10.90M |
June 30, 2022 | 10.76M |
March 31, 2022 | 10.24M |
December 31, 2021 | 9.83M |
September 30, 2021 | 7.843M |
June 30, 2021 | 5.554M |
March 31, 2021 | 2.892M |
Date | Value |
---|---|
December 31, 2020 | 0.5019M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 7.265M |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 2.586M |
September 30, 2018 | 3.753M |
June 30, 2018 | 5.324M |
March 31, 2018 | 6.278M |
December 31, 2017 | 6.938M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Jun 2020
15.73M
Maximum
Sep 2023
8.860M
Average
10.24M
Median
Mar 2022
Gross Profit (TTM) Benchmarks
United Therapeutics Corp | 2.220B |
AIM ImmunoTech Inc | 0.143M |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 37.16M |
Armata Pharmaceuticals Inc | -- |